Evaluation of dodecylmaltoside as a permeability enhancer for insulin using human carcinoma cells
β Scribed by Phani Prasanth Tirumalasetty; John G. Eley
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 142 KB
- Volume
- 94
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
β¦ Synopsis
Dodecylmaltoside (DDM), an alkylglycoside showing tissue-permeabilityenhancing properties, has been successful in improving nasal and ocular transport of poorly absorbed drugs. It was hypothesized that optimization of DDM concentration would improve the transport of insulin across epithelial monolayers without causing cell damage. Samples of markers and insulin were collected over a 6-h period and transepithelial electrical resistance was measured at concurrent time points to ascertain the effect of DDM on tight junctions. Samples were analyzed for lucifer yellow and insulin using reversed-phase high-performance liquid chromatography and for 3 [H]-mannitol by scintillation counting. A significant increase in the transport of markers and insulin was recorded in DDM-treated cells compared with controls. DDM enhanced the transport of markers and insulin in a concentration-dependent manner. Decreased transepithelial electrical resistance values confirmed that enhanced transport is caused by loosening of tight junctions. Cell recovery was >95% in 8 h indicating the potential of DDM as a penetration enhancer for clinical administration of insulin and other poorly absorbed drugs without causing cell damage.
π SIMILAR VOLUMES
## Abstract Poly[methacrylic acidβgraftedβpoly(ethylene glycol)] [P(MAAβ__g__βEG)] is a complexation hydrogel molecularly designed for oral peptide delivery. In this work, the cytotoxicity and insulinβtransport enhancing effect of P(MAAβ__g__βEG) microparticles on intestinal epithelial cells were e
## Background: Although experimental studies have demonstrated an important role of insulin-like growth factor i (igf-i) in hepatocarcinogenesis, the clinical data about igf-i in patients with hepatocellular carcinoma (hcc) are scarce and controversial. to the authors' knowledge, this is the first
A relatively simple, widely applicable, and robust in vitro method of predicting blood-brain barrier (BBB) permeability to central nervous system-acting drugs is an increasing need. A cell-based model offers the potential to account for transcellular and paracellular drug diffusional processes, meta